| Dr Xin Ruppel, PHARMD/MBA | |
|
1000 N Oak Ave # Fhp, Marshfield, WI 54449-5703 | |
| (715) 389-7474 | |
| (715) 221-8748 |
| Full Name | Dr Xin Ruppel |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1000 N Oak Ave # Fhp, Marshfield, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093902975 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15050-040 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Xin Ruppel, PHARMD/MBA 1000 N Oak Ave, Lq4, Marshfield, WI 54449-5703 Ph: (715) 221-7108 | Dr Xin Ruppel, PHARMD/MBA 1000 N Oak Ave # Fhp, Marshfield, WI 54449-5703 Ph: (715) 389-7474 |
News Archive
A new study suggests that men with localized prostate cancer living in more highly populated areas are more likely to be treated with surgery or radiation compared to men residing in less populated areas.
Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced the presentation of data on its novel resolvins for the treatment of both ocular surface diseases and retinal diseases at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale, Florida, being held May 2-6, 2010.
"As the recession has cost more people their jobs and their health insurance, local hospitals have seen more patients show up with no way to pay," reports KUOW, a Washington State public radio station.
An international study found that despite widespread acceptance that mental illness is a disease that can be effectively treated, a common "backbone" of prejudice exists that unfairly paints people with conditions such as depression and schizophrenia as undesirable for close personal relationships and positions of authority.
Envisia Therapeutics, a clinical-stage biotechnology company focused on the development of novel extended-release therapies in ophthalmology, today reported results from its first clinical trial of the Company's lead product candidate, ENV515 (travoprost XR).
› Verified 5 days ago
Keith Koscielski, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1306 N Central Ave, Marshfield, WI 54449 Phone: 715-387-3705 | |
Norbert Michael Salamonski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1012 N Central Ave, Marshfield, WI 54449 Phone: 715-384-9703 | |
Noah James Thurber, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 N Central Ave, Marshfield, WI 54449 Phone: 715-486-9439 | |
Dr. Paul M Evans, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-221-7737 | |
Allison Lessard, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 611 N Saint Joseph Ave, Pharmacy, Marshfield, WI 54449 Phone: 715-387-7687 | |
Dr. Michael Heltne, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 N Central Ave, Marshfield, WI 54449 Phone: 715-486-9439 |